Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
Construction of the plant will commence in 2025 with first production expected to be in 2027
Emcure will play a crucial role in ensuring the availability of high-quality, low-cost versions of lenacapavir in 120 countries
Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
Subscribe To Our Newsletter & Stay Updated
